# Allergy * **Definition:** A condition in which the immune system reacts abnormally to a foreign substance, leading to a range of symptoms that can vary from mild to severe, including skin reactions, upset stomach, and breathing difficulties. * **Taxonomy:** Specialties / Allergy ## News * Selected news on the topic of **Allergy**, for healthcare technology leaders * 5.9K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/21/2025 | [**Proposed algorithm to assess and de-label false penicillin allergy labels**](https://medicalxpress.com/news/2025-05-algorithm-de-false-penicillin-allergy.html) | [[MedicalXpress]] | | 5/20/2025 | [**Three Physicians at Allergy & Asthma Associates of Michigan Named 2025 Castle Connolly ...**](https://www.prnewswire.com/news-releases/three-physicians-at-allergy--asthma-associates-of-michigan-named-2025-castle-connolly-top-doctors-for-the-10th-consecutive-year-302458459.html) | [[PR Newswire]] | | 5/20/2025 | [**Three Physicians at Allergy & Asthma Associates of Michigan Named 2025 Castle Connolly ...**](https://finance.yahoo.com/news/three-physicians-allergy-asthma-associates-120000680.html) | [[Yahoo Finance]] | | 5/13/2025 | [**Filtrete™ Brand Earns Asthma & Allergy Friendly® Certification for Expanded Range of Air Filters, including new Refillable Platform**](https://www.prweb.com/releases/filtrete-brand-earns-asthma--allergy-friendly-certification-for-expanded-range-of-air-filters-including-new-refillable-platform-302453493.html) | [[PRWeb]] | | 4/30/2025 | [**Make Asthma and Allergy Treatments Accessible for All**](https://www.globenewswire.com/news-release/2025/04/30/3071693/0/en/Make-Asthma-and-Allergy-Treatments-Accessible-for-All.html) | [[Globe Newswire]] | | 4/23/2025 | [**Optimize Allergy Management in Primary Care**](https://www.medscape.com/viewarticle/optimize-allergy-management-primary-care-2025a10009u9) | [[Medscape]] | | 4/15/2025 | [**RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development**](https://www.globenewswire.com/news-release/2025/04/15/3061636/0/en/RAPT-Therapeutics-Deepens-Expertise-in-Allergic-Diseases-with-Appointment-of-Jessica-Savage-M-D-M-H-S-as-Vice-President-Clinical-Development.html) | [[Globe Newswire]] | | 3/24/2025 | [**Neil Hockstein, MD of ENT & Allergy of Delaware Appointed by Delaware Governor Matthew ...**](https://www.prnewswire.com/news-releases/neil-hockstein-md-of-ent--allergy-of-delaware-appointed-by-delaware-governor-matthew-meyer-to-lead-the-delaware-health-commission-302408338.html) | [[PR Newswire]] | | 3/18/2025 | [**Pollen Seasons are Longer and More Intense, Affecting Millions**](https://www.globenewswire.com/news-release/2025/03/18/3044347/0/en/Pollen-Seasons-are-Longer-and-More-Intense-Affecting-Millions.html) | [[Globe Newswire]] | | 3/18/2025 | [**Pollen Seasons are Longer and More Intense, Affecting Millions - Yahoo Finance**](https://finance.yahoo.com/news/pollen-seasons-longer-more-intense-110000275.html) | [[Yahoo Finance]] | | 3/12/2025 | [**Align ENT + Allergy Partners with Princeton Allergy & Asthma Associates**](https://www.prnewswire.com/news-releases/align-ent--allergy-partners-with-princeton-allergy--asthma-associates-302400218.html) | [[PR Newswire]] | | 3/6/2025 | [**It's allergy season in Oklahoma. See what's causing your sniffles and how to combat pollen**](https://www.yahoo.com/lifestyle/allergy-season-oklahoma-see-whats-112014952.html) | [[Yahoo]] | | 3/4/2025 | [**Formula Soon After Birth Linked to Food Allergy Risk**](https://www.medpagetoday.com/meetingcoverage/aaaai/114477) | [[Medpage Today]] | | 3/3/2025 | [**Omalizumab Effective at Treating Multi-Food Allergy**](https://www.insideprecisionmedicine.com/topics/patient-care/omalizumab-effective-at-treating-multi-food-allergy/) | [[Inside Precision Medicine]] | | 2/20/2025 | [**Blueair Earns Asthma & Allergy Friendly® Certification for Its Classic Pro CP7i Air Purifier**](https://www.prweb.com/releases/blueair-earns-asthma--allergy-friendly-certification-for-its-classic-pro-cp7i-air-purifier-302380585.html) | [[PRWeb]] | | 2/18/2025 | [**Global Allergy Diagnostics Market to Observe Growth at a CAGR of ~12y 2032 - DelveInsight**](https://www.globenewswire.com/news-release/2025/02/18/3028174/0/en/Global-Allergy-Diagnostics-Market-to-Observe-Growth-at-a-CAGR-of-12-by-2032-DelveInsight.html) | [[Globe Newswire]] | | 2/18/2025 | [**Global Allergy Diagnostics Market to Observe Growth at a CAGR of ~12y 2032 - DelveInsight**](https://finance.yahoo.com/news/global-allergy-diagnostics-market-observe-180000511.html) | [[Yahoo Finance]] | | 2/17/2025 | [**Elevating Indoor Air Quality Standards: Kimberly-Clark's New Kleenex® Air Filters Earn Asthma & Allergy Friendly® Certification**](https://www.prweb.com/releases/elevating-indoor-air-quality-standards-kimberly-clarks-new-kleenex-air-filters-earn-asthma--allergy-friendly-certification-302377493.html) | [[PRWeb]] | | 2/12/2025 | [**Hematopoietic Stem Cell Transplant Patients Rarely Tested for Penicillin Allergy**](https://www.prweb.com/releases/hematopoietic-stem-cell-transplant-patients-rarely-tested-for-penicillin-allergy-302374570.html) | [[PRWeb]] | | 2/11/2025 | [**Oral Immunotherapy Works for High-Tolerance Peanut Allergy Too**](https://www.medpagetoday.com/allergyimmunology/allergy/114172) | [[Medpage Today]] | | 2/11/2025 | [**Food Allergies in Children Associated with Risk of Anxieties and Bullying**](https://www.prweb.com/releases/food-allergies-in-children-associated-with-risk-of-anxieties-and-bullying-302373754.html) | [[PRWeb]] | | 1/6/2025 | [**Science Awards for Allergy 2025: Call for Applications - Yahoo Finance**](https://finance.yahoo.com/news/science-awards-allergy-2025-call-094000444.html) | [[Yahoo Finance]] | | 9/13/2024 | [**Best at-home allergy tests - Fortune Recommends Health**](https://fortune.com/recommends/health/best-at-home-allergy-test/) | [[Fortune]] | | 8/1/2024 | [**Food Allergy Fund's Exclusive Research Roadmap Accelerates Food Allergy Prevention and a Cure**](http://www.businesswire.com/news/home/20240801736937/en/Food-Allergy-Funds-Exclusive-Research-Roadmap-Accelerates-Food-Allergy-Prevention-and-a-Cure/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 7/18/2024 | [**Allergy Shot Market Revenue Estimated to Grow at 6.1% CAGR to Reach US$ 3.34 Billion by 2034: Fact.MR Report**](https://www.globenewswire.com/news-release/2024/07/18/2915385/0/en/Allergy-Shot-Market-Revenue-Estimated-to-Grow-at-6-1-CAGR-to-Reach-US-3-34-Billion-by-2034-Fact-MR-Report.html) | [[Globe Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Allergy & Asthma Network**: A leading nonprofit organization focused on patient education and advocacy for individuals with asthma and allergies. - **Align ENT + Allergy**: A management services organization that supports physician-led practices in allergy care. - **Asthma and Allergy Foundation of America (AAFA)**: A leading non-profit organization dedicated to supporting individuals with asthma and allergies through research, education, advocacy, and community programs. - **Alerje, Inc.**: A company focused on personalized allergy care solutions through advanced diagnostic platforms. - **Parallel ENT & Allergy**: A healthcare provider specializing in allergy management and practice management services. - **Latitude Food Allergy Care**: A clinic dedicated to food allergy diagnosis and treatment, expanding access to care. - **American Academy of Allergy, Asthma & Immunology (AAAAI)**: A key organization supporting initiatives to improve patient outcomes related to allergies. - **AllerVie Health**: A national network of allergists and immunologists focused on delivering high-quality patient care and enhancing clinical practices. - **ALK**: A global specialty pharmaceutical company focused on allergy treatments, headquartered in Denmark. - **NIAID**: National Institute of Allergy and Infectious Diseases, involved in research and guidelines for allergy prevention and management. - **Allergy and Asthma Care (AAC)**: A leading provider in allergy and asthma care for over 45 years, joining the new ENTA-PA model to improve patient-centric care. - **Allermi**: A telehealth company innovating personalized allergy care through compounded nasal sprays. - **Thermofisher Scientific**: A key player in the allergy diagnostics market, particularly in drug allergy testing. - **Food Allergy Institute (FAI)**: An organization focused on advancing the understanding and treatment of food allergies, utilizing innovative research and patient-centered care. - **ModuleMD**: A technology company integrating AI into EHR systems to improve efficiency and diagnostic accuracy in allergy and other specialties. ### Partnerships and Collaborations - **Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL)**: Collaboration to certify products that improve indoor air quality for allergy sufferers. - **Align ENT + Allergy and Princeton Allergy & Asthma Associates**: A partnership aimed at enhancing the presence of allergy specialists in New Jersey and providing better patient care. - **Asthma & Allergy Friendly Certification Program**: A collaboration between Allergy Standards Limited (ASL) and the Asthma and Allergy Foundation of America (AAFA) to certify products that promote healthier indoor environments. - **Asthma & Allergy Friendly® Certification Program**: A collaboration between AAFA and ASL to certify products that improve indoor air quality. - **Parallel ENT & Allergy and Allergy & Asthma Associates of Michigan**: Collaboration to enhance patient care through non-clinical practice management services. - **Food Allergy Fund**: Launched a Food Allergy Research Roadmap to accelerate discovery and development in the food allergy community. - **ENTA - PA**: Collaboration between QMMS USA and AAC to create a new model for allergy care in Pennsylvania, promoting resource sharing and collaboration among clinicians. - **Mitsubishi Gas Chemical Company and Alerje, Inc.**: A strategic partnership aimed at enhancing global allergy diagnosis and treatment, focusing on advanced diagnostic platforms and personalized care. - **Mitsubishi Gas Chemical Company + Alerje, Inc.**: A strategic partnership to enhance allergy diagnosis and treatment globally. - **Mitsubishi Gas Chemical Company and Alerje**: A strategic partnership aimed at enhancing allergy diagnosis and treatment globally. - **AAFA and ASL**: Collaboration on the Asthma & Allergy Friendly® Certification Program to help consumers identify products that improve indoor air quality. - **Align ENT + Allergy and Melnick, Moffitt, & Mesaros ENT Associates**: A partnership aimed at enhancing local healthcare services while maintaining practice individuality. - **SoundHealth**: Sponsor of research studies focusing on nasal anatomy and allergy symptoms, aiming to enhance treatment strategies through advanced modeling techniques. - **Circuit Clinical + Mercer Allergy & Pulmonary Associates**: A collaboration to integrate clinical trials into existing patient care for advanced medical solutions. - **AAAAI and PAVE Act**: Collaboration to introduce the Penicillin Allergy Verification and Evaluation Act to improve patient outcomes and reduce healthcare costs. - **FARE and Local Restaurants**: Collaboration to train food service workers on managing food allergies and ensuring safe dining experiences. - **Acquisition**: ENTA's acquisition of Advanced ENT & Allergy, Detail: Integrates 38 providers and 11 locations to expand services in New Jersey and Pennsylvania. - **Polyrizon and Eurofins CDMO**: A manufacturing agreement to produce Clinical Trial Material for Polyrizon's allergy blocker, PL-14. - **University of Queensland Project**: Aims to enhance safety for teenagers with food allergies, funded by the National Health and Medical Research Council. - **QHSLab Inc.**: Secured a grant for research on digital health tools for allergic rhinitis, emphasizing commitment to chronic care. ### Innovations, Trends, and Initiatives - **Asthma & Allergy Friendly® Certification**: A program that certifies products meeting strict scientific standards for safety and effectiveness for individuals with asthma and allergies. - **Allergy Season Trends**: Increasing severity and duration of allergy seasons, with rising pollen counts impacting patient care. - **AI in Allergy Prediction**: Researchers are using AI and online data to analyze seasonal allergy patterns, enhancing understanding of allergy occurrences. - **2025 Allergy Capitals Report**: AAFA's report identifying U.S. cities with the most challenging conditions for allergy sufferers, highlighting the impact of climate change on allergy seasons. - **Algorithm for Penicillin Allergy**: Developed by Monash University to educate patients about incorrect penicillin allergy labels, aiming to improve antibiotic prescribing. - **AI Integration**: ModuleMD is transforming allergy practices by integrating AI tools into EHR systems, enhancing diagnostic accuracy and operational efficiency. - **AI and Data Analytics**: Transforming allergy diagnostics and treatment approaches, enhancing clinical decision-making and patient engagement. - **Allergy Diagnostics Market Growth**: Rapid growth driven by increasing prevalence of allergic diseases and advancements in diagnostic technologies. - **AI-Enabled Digital Health Tools**: Alerje is revolutionizing food allergy management with AI tools and a patented epinephrine auto-injector to enhance treatment outcomes. - **Growth of Allergy Diagnostics Market**: The global market for allergy diagnostics and therapeutics is projected to grow significantly, driven by advancements in diagnostic technologies and increasing prevalence of allergic diseases. - **Nanoparticle Allergy Immunotherapy**: Research from the University of Michigan shows allergen-encapsulating nanoparticles can prevent anaphylaxis in mice, suggesting a new approach to allergy treatment. - **Food Allergy Research Roadmap**: A comprehensive plan to address food allergies through innovative prevention and treatment strategies. - **RELMb Research**: Studies indicate that targeting the protein RELMb could lead to new therapies for food allergies by restoring immune tolerance. - **Omalizumab (Xolair)**: A monoclonal antibody treatment shown to be more effective than oral immunotherapy for multi-food allergies. - **Research on Metabolites**: Studies are investigating the role of metabolites in food allergies, aiming to develop effective therapies. - **ACARIZAX® Recommendation**: NICE has recommended ACARIZAX® for treating house dust mite allergic rhinitis, marking a significant advancement in allergy immunotherapy. - **New Therapies**: LongBio's LP-003 aims to provide long-lasting relief for food allergies, with ongoing trials for various allergic conditions. - **Allergen ImmunoButters™**: A product line designed to help families introduce allergens early in children's diets, promoting a healthy gut microbiome. - **Penicillin Allergy Delabeling**: Research supports the safety of direct penicillin challenges, advocating for routine delabeling to improve antibiotic use and patient care. - **Food Allergy Fund's Research Grant**: Funding aimed at repurposing existing FDA-approved drugs for food allergy treatment. ### Challenges and Concerns - **Access to Allergy Specialists**: Challenges in accessing allergy specialists in high-allergy burden areas, as highlighted in the 2025 Allergy Capitals report. - **Rising Allergy Prevalence**: The increasing severity and prevalence of allergies necessitate new treatment approaches and better management strategies. - **Food Allergy Diagnosis**: Accurate diagnosis is essential for effective management, with challenges in distinguishing between sensitization and clinical allergy. - **Food Allergy Awareness**: The need for increased awareness and protective measures for food allergies, particularly among children. - **Rising Allergy Rates**: Environmental factors, including climate change and pollution, are contributing to longer and more intense allergy seasons. - **Mislabeling of Allergies**: A review indicates that many individuals labeled as penicillin allergic may not actually have the allergy, leading to unnecessary healthcare costs. - **Inaccurate Allergy Records**: Many patients have outdated or incorrect allergy records, which can hinder optimal care and contribute to adverse health outcomes. - **Environmental Factors**: Deteriorating environmental conditions, particularly in industrialized regions, are contributing to the rise in allergic diseases. - **Psychological Distress in Allergy Patients**: A significant number of individuals with food allergies experience psychological distress, with minimal support available. - **Rising Food Allergy Prevalence**: A significant increase in food allergies, particularly among children, is creating a demand for effective treatments. - **Food Allergy Prevalence**: Over 33 million Americans affected, highlighting the need for better policies and awareness in public spaces. - **Misconceptions about Allergies**: The need for effective communication strategies to address misconceptions about penicillin allergies, as many patients are incorrectly labeled. - **Increasing Prevalence of Food Allergies**: The rising incidence of food allergies, particularly among children, necessitates urgent advancements in treatment and management. - **Access to Allergy Care**: The closure of allergy departments in healthcare facilities, such as in Chillicothe, Ohio, leaves patients without treatment options. - **Healthcare Disparities**: Research indicates higher rates of allergies among minority populations, highlighting the need for more comprehensive data and targeted interventions. - **Misdiagnosis of Antibiotic Allergies**: A significant percentage of suspected antibiotic allergies in children are misdiagnosed, leading to unnecessary avoidance of essential medications. - **Inaccurate Allergy Labels**: Study highlights the prevalence of inaccurate penicillin allergy labels in immunocompromised patients, limiting access to effective antibiotics and emphasizing the need for better evaluation practices. - **FDA Warning**: A warning regarding severe itching (pruritus) that can occur after discontinuing certain allergy medications, highlighting the need for patient education. - **Climate Change Impact**: The changing climate is extending allergy seasons, with public health implications for managing seasonal allergies.